If topline data is released and the #s are consistent with what longs have assumed for so long--- that DCVAX-L is efficacious-- there is no way most longs will sell their position for a $1. An expansion of DCVax-L use for other cancers, a definite buyout and/or partnerships, approval of Direct as well as nearly world-wide commercialization and distribution would be likely in the cards in the not-too-distant future... if topline proves efficacy.
It is ludicrous to think longs, who have held their position while stock fell 90%+ and average down despite the unrelenting negative onslaught and manipulation, will sell out their position after topline/the validation of the science but before market understands NWBO's full potential.
If the stock was at $12 and fell to .50 in one year and we didn't sell a share, what could ever convince you to think that longs, in any significant number, will sell again after the science is validated but before the market fully understands what NWBO has done.
Your position is untenable.
News 
Market Data 
Discover 
